{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:26Z","timestamp":1791357266228,"version":"4.3.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jneuroim.2004.01.006","type":"journal-article","created":{"date-parts":[[2004,2,24]],"date-time":"2004-02-24T10:15:49Z","timestamp":1077617749000},"page":"116-122","source":"Crossref","is-referenced-by-count":98,"title":["Immunologic variables in acute mania of bipolar disorder"],"prefix":"10.1016","volume":"150","author":[{"given":"Hsing-Cheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yech-Mei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Po","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston W","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sy-Jye","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2004.01.006_BIB1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.mp.4000650","article-title":"Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment","volume":"5","author":"Arolt","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.mp.4000650","article-title":"Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment","volume":"5","author":"Arolt","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB4","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.160.8.3642","article-title":"IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+T lymphocytes","volume":"160","author":"Barbulescu","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0165-1781(89)90039-5","article-title":"Reduced cellular immune function in major depression and mania","volume":"29","author":"Barsi","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(94)00299-I","article-title":"Cytokine production in drug-free and neuroleptic-treated schizophrenic patients","volume":"38","author":"Bessler","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.1997.00285.x","article-title":"The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers","volume":"91","author":"Bleeker","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB8","first-page":"563","article-title":"Interleukin-1, tumor necrosis factor and their specific inhibitors","volume":"5","author":"Dayer","year":"1994","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0167-5699(91)90142-G","article-title":"Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro","volume":"12","author":"Dinarello","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJM199301143280207","article-title":"The role of interleukin-1 in disease","volume":"328","author":"Dinarello","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB12","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V79.9.2196.2196","article-title":"Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease","volume":"79","author":"Fischer","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB13","first-page":"16","article-title":"The macrophage and neuropsychiatric disorders","volume":"9","author":"Fricchione","year":"1996","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2249.1991.tb05785.x","article-title":"Serum soluble CD4 and CD8 levels in Kawasaki disease","volume":"86","author":"Furukawa","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-1781(92)90046-6","article-title":"Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production","volume":"44","author":"Ganguli","year":"1992","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1192\/bjp.162.5.651","article-title":"Impaired in vivo immune responses in patients with melancholia","volume":"162","author":"Hickie","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0920-9964(94)00046-B","article-title":"Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia","volume":"15","author":"Hornberg","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0006-3223(97)00357-0","article-title":"Decreased interleukin-2 production in Korean schizophrenic patients","volume":"43","author":"Kim","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-3223(88)90204-1","article-title":"Immune function in mania","volume":"24","author":"Kronfol","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Cytokines and the brain: implications for clinical psychiatry","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI115457","article-title":"Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue","volume":"88","author":"Kurane","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","article-title":"Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production","volume":"84","author":"Maes","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0447.1992.tb03292.x","article-title":"Immune disorders in depression: higher T helper\/T suppressor-cytotoxic cell ratio","volume":"86","author":"Maes","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","article-title":"Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine","volume":"89","author":"Maes","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0306-4530(94)00066-J","article-title":"The monocyte-T-lymphocyte hypothesis of major depression","volume":"20","author":"Maes","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-0327(95)00049-6","article-title":"Increased serum interleukin-1-receptor-antagonist concentrations in major depression","volume":"36","author":"Maes","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(96)00029-1","article-title":"Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs","volume":"21","author":"Maes","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0006-3223(95)00627-3","article-title":"Increased serum soluble CD8 or suppressor\/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids","volume":"40","author":"Maes","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0920-9964(97)00057-1","article-title":"In vivo immunomodulatory effects of clozapine in schizophrenia","volume":"26","author":"Maes","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002130050965","article-title":"In vitro immunoregulatory effects of lithium in healthy volunteers","volume":"143","author":"Maes","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0924-977X(99)00062-0","article-title":"Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics","volume":"10","author":"Maes","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","article-title":"Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition","volume":"105","author":"Maier","year":"1998","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB37","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1037\/0003-066X.49.12.1004","article-title":"Psychoneuroimmunology. The interface between behavior, brain, and immunity","volume":"49","author":"Maier","year":"1994","journal-title":"Am. Psychol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB38","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0006-3223(99)00235-8","article-title":"Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness","volume":"46","author":"Manji","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2004.01.006_BIB39","first-page":"27","article-title":"Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications","volume":"60","author":"Manji","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/030089160008600208","article-title":"In vitro interleukin-8 production by monocytes treated with lithium chloride from breast cancer patients","volume":"86","author":"Merendino","year":"2000","journal-title":"Tumori"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1126\/science.8023139","article-title":"Cytokine patterns during the progression to AIDS","volume":"265","author":"Mosmann","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(97)00179-6","article-title":"Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders","volume":"22","author":"Muller","year":"1998","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-1781(96)02824-7","article-title":"Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder","volume":"65","author":"O'Donnell","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB47","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.4049\/jimmunol.160.4.1742","article-title":"IFN-gamma-inducing factor\/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects","volume":"160","author":"Osaki","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/infdis\/165.5.799","article-title":"Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection","volume":"165","author":"Peakman","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB49","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1084\/jem.170.5.1751","article-title":"Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells","volume":"170","author":"Peleman","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB50","first-page":"249","article-title":"Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia","volume":"5","author":"Pui","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","article-title":"Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?","volume":"59","author":"Rapoport","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-3223(01)01144-1","article-title":"The effects of lithium on ex vivo cytokine production","volume":"50","author":"Rapaport","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.1991.01810300025004","article-title":"The mechanisms of action of lithium: II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects","volume":"48","author":"Risby","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1074-7613(00)80378-7","article-title":"IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB","volume":"7","author":"Robinson","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB55","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0006-3223(96)00360-5","article-title":"Production of cytokines in acute schizophrenic psychosis","volume":"40","author":"Rothermundt","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/brbi.2001.0647","article-title":"T-helper-1 and T-helper-2 responses in psychiatric disorders","volume":"15","author":"Schwarz","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","article-title":"The macrophage-T-lymphocyte theory of schizophrenia: additional evidence","volume":"45","author":"Smith","year":"1995","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-0327(94)90135-X","article-title":"Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls","volume":"30","author":"Song","year":"1994","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-0327(01)00369-X","article-title":"Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission","volume":"71","author":"Su","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0090-1229(91)90113-O","article-title":"Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis","volume":"60","author":"Symons","year":"1991","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-1781(00)00196-7","article-title":"Serum interleukin-18 levels are elevated in schizophrenia","volume":"96","author":"Tanaka","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB62","first-page":"249","article-title":"Co-existing physical illness in help-seeking patients of bipolar disorder","volume":"11","author":"Tsai","year":"1997","journal-title":"Taiwan. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB63","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-3223(98)00159-0","article-title":"Activation of indices of cell-mediated immunity in bipolar mania","volume":"45","author":"Tsai","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","author":"Tsai","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB65","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.4049\/jimmunol.156.11.4274","article-title":"Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein","volume":"156","author":"Ushio","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10238-001-8024-1","article-title":"Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1","volume":"1","author":"Verrotti","year":"2001","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2249.1994.tb06081.x","article-title":"Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis","volume":"97","author":"Vitale","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02190280","article-title":"Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients","volume":"246","author":"Wilke","year":"1996","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2004.01.006_BIB69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:44:14Z","timestamp":1682642654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572804000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":69,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0165572804000141"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.01.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}